NLS Pharmaceutics Ltd (NLSP)
3.60
-0.03
(-0.83%)
USD |
NASDAQ |
Nov 01, 16:00
3.60
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Market Cap: 13.73M for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 13.73M |
| October 31, 2024 | 13.85M |
| October 30, 2024 | 14.73M |
| October 29, 2024 | 15.76M |
| October 28, 2024 | 15.68M |
| October 25, 2024 | 15.95M |
| October 24, 2024 | 16.25M |
| October 23, 2024 | 17.57M |
| October 22, 2024 | 18.47M |
| October 21, 2024 | 11.76M |
| October 18, 2024 | 13.10M |
| October 17, 2024 | 12.80M |
| October 16, 2024 | 12.55M |
| October 15, 2024 | 11.79M |
| October 14, 2024 | 11.34M |
| October 11, 2024 | 11.00M |
| October 10, 2024 | 10.50M |
| October 09, 2024 | 5.973M |
| October 08, 2024 | 6.188M |
| October 07, 2024 | 5.935M |
| October 04, 2024 | 5.743M |
| October 03, 2024 | 5.714M |
| October 02, 2024 | 5.837M |
| October 01, 2024 | 6.094M |
| September 30, 2024 | 5.942M |
| Date | Value |
|---|---|
| September 27, 2024 | 6.094M |
| September 26, 2024 | 5.86M |
| September 25, 2024 | 6.202M |
| September 24, 2024 | 6.516M |
| September 23, 2024 | 6.356M |
| September 20, 2024 | 7.078M |
| September 19, 2024 | 6.417M |
| September 18, 2024 | 6.413M |
| September 17, 2024 | 6.670M |
| September 16, 2024 | 6.375M |
| September 13, 2024 | 6.338M |
| September 12, 2024 | 6.188M |
| September 11, 2024 | 6.052M |
| September 10, 2024 | 5.813M |
| September 09, 2024 | 5.892M |
| September 06, 2024 | 6.117M |
| September 05, 2024 | 6.661M |
| September 04, 2024 | 6.797M |
| September 03, 2024 | 6.802M |
| August 30, 2024 | 6.989M |
| August 29, 2024 | 7.083M |
| August 28, 2024 | 7.364M |
| August 27, 2024 | 8.110M |
| August 26, 2024 | 7.576M |
| August 23, 2024 | 7.482M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.935M
Minimum
Jun 14 2024
68.98M
Maximum
Mar 12 2021
24.08M
Average
20.87M
Median
Oct 20 2023
Market Cap Benchmarks
| AC Immune SA | 296.82M |
| CRISPR Therapeutics AG | 4.323B |
| Addex Therapeutics Ltd | 11.44M |
| Molecular Partners AG | 203.08M |
| MoonLake Immunotherapeutics | 2.941B |
Market Cap Related Metrics
| Price | 3.60 |
| Earnings Yield | -187.2% |